Lamivudine / Zidovudine

Common brands: Combivir, Kaletra, Norvir, Retrovir, Viread

Top reporter: Viiv Healthcare Company

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 3A Inhibitor [EPC]Protease Inhibitor [EPC]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
7,692
Total Reports
1,243
Serious Reports
589
Death Reports
30
Reported Reactions
Death Report Ratio: High (7.66%)

Patient Demographics

Male
3,284
Female
3,601

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lamivudine / Zidovudine.

# Reaction Reports % of Total
1 DRUG EXPOSURE DURING PREGNANCY 1,146
11.1%
2 FOETAL EXPOSURE DURING PREGNANCY 710
6.9%
3 PAIN 601
5.8%
4 ANXIETY 568
5.5%
5 EMOTIONAL DISTRESS 557
5.4%
6 ANHEDONIA 504
4.9%
7 ANAEMIA 453
4.4%
8 ABORTION SPONTANEOUS 443
4.3%
9 MATERNAL EXPOSURE DURING PREGNANCY 381
3.7%
10 PREMATURE BABY 362
3.5%
11 CHRONIC KIDNEY DISEASE 327
3.2%
12 PYREXIA 284
2.7%
13 STILLBIRTH 278
2.7%
14 NAUSEA 270
2.6%
15 OSTEOPOROSIS 269
2.6%
16 RENAL FAILURE 269
2.6%
17 DEPRESSION 267
2.6%
18 FATIGUE 262
2.5%
19 EXPOSURE DURING PREGNANCY 257
2.5%
20 DIARRHOEA 246
2.4%
21 VOMITING 234
2.3%
22 ASTHENIA 196
1.9%
23 BONE DENSITY DECREASED 195
1.9%
24 PREGNANCY 194
1.9%
25 ECONOMIC PROBLEM 190
1.8%
26 ABORTION INDUCED 188
1.8%
27 RENAL IMPAIRMENT 181
1.7%
28 OSTEOPENIA 178
1.7%
29 CAESAREAN SECTION 169
1.6%
30 HEADACHE 168
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.